Area of research
Hepatology · Molecular Biology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, and Cancer-related molecular mechanisms research.
Immune checkpoint inhibitor-related adrenal hypofunction and Psoriasisby induced by tislelizumab: A case report and review of literature
METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma
METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
Targeting tumour-intrinsic N <sup>7</sup> -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy
Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism